期刊名：Therapeutics

期刊主页：https://www.mdpi.com/journal/therapeutics

Therapeutics (ISSN 2813-9909) 是一本国际同行评审的开放获取学术期刊。本刊致力于发表人类疾病预防与治疗领域的前沿研究，涵盖现代及传统成熟治疗技术。本刊刊载综述、原创研究、指南、通讯等类型，并鼓励学者尽可能详细地发表其实验和理论成果，包括可能被视为“负面”的结果。

1. Effects of Daratumumab (Anti-CD38) Monoclonal Antibody Therapy on Flow Cytometry Analysis in Multiple Myeloma

《达雷妥尤单抗（抗 CD38）单克隆抗体疗法对多发性骨髓瘤流式细胞术分析的影响》

文章链接：https://www.mdpi.com/2813-9909/2/1/2

引用: Germans, S.K.; Kahlow, C.W.; Chen, W.; Fuda, F. Effects of Daratumumab (Anti-CD38) Monoclonal Antibody Therapy on Flow Cytometry Analysis in Multiple Myeloma. Therapeutics 2025, 2, 2.

2. Pharmacologic Management of Anticoagulation in Patients with Hepatic Cirrhosis: A Review of Dosing and Monitoring Strategies

《肝硬化患者抗凝治疗的药物管理：剂量与监测策略的综述》

文章链接: https://www.mdpi.com/2813-9909/2/2/8

引用: Gutgsell, D.N.; Regal, R.E. Pharmacologic Management of Anticoagulation in Patients with Hepatic Cirrhosis: A Review of Dosing and Monitoring Strategies. Therapeutics 2025, 2, 8.

3. How Natural Therapies Can Combat Neoplastic Disease by Targeting Key Survival Mechanisms and Signaling Pathways

《如何通过靶向关键的生存机制和信号通路来利用自然疗法对抗肿瘤性疾病》

文章链接：http://www.mdpi.com/2813-9909/2/1/5

引用: Karagil, S.; Szczesnowska, A.; Haddad, N.; Magura Gamaethige, S.; Coakley, E.; Dawood, N.; Rama, V.J.; Barker, J.; Langat, M.K.; Morgan, H.; et al. How Natural Therapies Can Combat Neoplastic Disease by Targeting Key Survival Mechanisms and Signaling Pathways. Therapeutics 2025, 2, 5.

4. Examining Benefits and Limitations to Treatment Outcome Measurement Tools for Substance Use Disorder: A Scoping Review

《评估用于测量药物使用障碍治疗效果的工具的优缺点：一项综述研究》

文章链接: https://www.mdpi.com/2813-9909/2/1/3

引用: Peters, D.; Kalathoor, J.; Phillips, C.; Andric, B.; Sacca, L. Examining Benefits and Limitations to Treatment Outcome Measurement Tools for Substance Use Disorder: A Scoping Review. Therapeutics 2025, 2, 3.

5. The Impact of Leptomeningeal Metastasis in Patients with Non-Small Cell Lung Cancer with EGFR Mutation: Survival Analysis of a Retrospective Cohort Study

《非小细胞肺癌伴有 EGFR 突变患者脑膜转移的影响：一项回顾性队列研究的生存分析》

文章链接: https://www.mdpi.com/2813-9909/2/2/7

引用: Giffoni de Mello Morais Mata, D.; Vargas, T.P.A.; Carmona, C.A.; Al-Humiqani, A.; Gehlaut, S.; Thawer, A.; Romero, M.; Doherty, M.K.; Menjak, I.B. The Impact of Leptomeningeal Metastasis in Patients with Non-Small Cell Lung Cancer with EGFR Mutation: Survival Analysis of a Retrospective Cohort Study. Therapeutics 2025, 2, 7.

6. The Golden Hamster: A Valuable Model for Designing Cancer Therapies

《金色仓鼠：设计癌症疗法的宝贵模型》

文章链接: https://www.mdpi.com/2813-9909/2/3/10

引用: Singer, M.; Imagawa, D.K.; Alexander, M.; Abi-Jaoudeh, N. The Golden Hamster: A Valuable Model for Designing Cancer Therapies. Therapeutics 2025, 2, 10.

7. A Broken Heart and Windy Nights: Single Center Results of Inpatient Sleep Studies and Interventions in Hospitalized Heart Failure Patients

《心碎和多风的夜晚：住院心力衰竭患者睡眠研究和干预的单中心结果》

文章链接: https://www.mdpi.com/2813-9909/2/1/1

引用: Durland, J.N.; Hoyland, F.; Epps, J.E.; Gregoski, M.J.; Angles, J.; Jackson, G.R. A Broken Heart and Windy Nights: Single Center Results of Inpatient Sleep Studies and Interventions in Hospitalized Heart Failure Patients. Therapeutics 2025, 2, 1.

8. Novel 2D/3D Hybrid Organoid System for High-Throughput Drug Screening in iPSC Cardiomyocytes

《用于诱导多能干细胞心肌细胞高通量药物筛选的新型二维/三维混合组织模型系统》

文章链接: https://www.mdpi.com/2813-9909/2/3/11

引用: Lewis, J.; Yaseen, B.; Wu, H.; Saraf, A. Novel 2D/3D Hybrid Organoid System for High-Throughput Drug Screening in iPSC Cardiomyocytes. Therapeutics 2025, 2, 11.

9. Patient and Healthcare Provider Perceptions of Handgrip Strength in an Internal Medicine Resident Clinic

《内科住院医师诊所中患者与医护人员对手部握力的感知》

文章链接: https://www.mdpi.com/2813-9909/2/1/4

引用: Mastrud, M.; Juhl, K.; Dahl, L.; Haiderbhai, S.; Lahr, P.; Manocha, G.; Olson, A.; Raum, J.; Theige, D.; McGrath, R. Patient and Healthcare Provider Perceptions of Handgrip Strength in an Internal Medicine Resident Clinic. Therapeutics 2025, 2, 4.

10. Safety and Clinical Impact of the Concomitant Use of Antifibrotic Drugs and Anticoagulants: A Single-Centre Retrospective Study

《抗纤维化药物与抗凝药物联合使用的安全性及临床影响：一项单中心回顾性研究》

文章链接: https://www.mdpi.com/2813-9909/2/2/9

引用: Pagano, A.; Bruni, M.; Tavanti, L.; Pistelli, F.; Chimera, D.; Carrozzi, L.; Celi, A.; Pancani, R. Safety and Clinical Impact of the Concomitant Use of Antifibrotic Drugs and Anticoagulants: A Single-Centre Retrospective Study. Therapeutics 2025, 2, 9.

本刊所有文章均以开放获取形式出版，一经发表即可供全球读者免费并无限制地阅读。我们致力于通过高效的同行评审与快速的出版流程，确保您的重要研究成果能以最快速度产生广泛影响力。我们期待您的投稿，如有疑问，敬请联络编辑部 (therapeutics@mdpi.com)。